Skip to main content
. 2018 May 23;7(7):2960–2968. doi: 10.1002/cam4.1565

Figure 6.

Figure 6

Exploration of the prognostic value of RP11‐466I1.1 in hepatocellular carcinoma (HCC). The expression of lncRNA in the specimen was calculated using the comparison 2‐∆CT method relative to GAPDH. The median expression level of lncLMA in HCC serum was used as the cutoff. Kaplan‐Meier analysis and log‐rank test were performed to evaluate the correlation between RP11‐466I1.1 expression and HCC survival and recurrence rate. High expression of RP11‐466I1.1 was correlated with lower survival rate (P = .0034) and higher recurrence rate (P < .0001)